CA2200986A1 - Medicaments - Google Patents

Medicaments

Info

Publication number
CA2200986A1
CA2200986A1 CA002200986A CA2200986A CA2200986A1 CA 2200986 A1 CA2200986 A1 CA 2200986A1 CA 002200986 A CA002200986 A CA 002200986A CA 2200986 A CA2200986 A CA 2200986A CA 2200986 A1 CA2200986 A1 CA 2200986A1
Authority
CA
Canada
Prior art keywords
integer
medicaments
hydrogen
fluorocarbon
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002200986A
Other languages
French (fr)
Other versions
CA2200986C (en
Inventor
Li Li-Bovet
Keith Arthur Johnson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
Li Li-Bovet
Keith Arthur Johnson
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9419536A external-priority patent/GB9419536D0/en
Application filed by Li Li-Bovet, Keith Arthur Johnson, Glaxo Wellcome Inc. filed Critical Li Li-Bovet
Publication of CA2200986A1 publication Critical patent/CA2200986A1/en
Application granted granted Critical
Publication of CA2200986C publication Critical patent/CA2200986C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Abstract

A pharmaceutical aerosol formulation which comprises particulate medicament, a fluorocarbon of hydrogen-containing chlorofluoro-carbon propellant and a surfactant of general formula (I), wherein n is an integer of 1 to 18; m is an integer of 0 to 17; and R1, R2 and R3 are each independently a hydrogen atom or a C1-4alkyl group.
CA002200986A 1994-09-28 1995-09-27 Medicaments Expired - Fee Related CA2200986C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9419536.9 1994-09-28
GB9419536A GB9419536D0 (en) 1994-09-28 1994-09-28 Medicaments
PCT/IB1995/000866 WO1996009816A1 (en) 1994-09-28 1995-09-27 Medicaments

Publications (2)

Publication Number Publication Date
CA2200986A1 true CA2200986A1 (en) 1996-04-04
CA2200986C CA2200986C (en) 2007-03-06

Family

ID=37891561

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002200986A Expired - Fee Related CA2200986C (en) 1994-09-28 1995-09-27 Medicaments

Country Status (1)

Country Link
CA (1) CA2200986C (en)

Also Published As

Publication number Publication date
CA2200986C (en) 2007-03-06

Similar Documents

Publication Publication Date Title
MX9702149A (en) Medicaments.
DE69111426T2 (en) FUEL PREPARATIONS.
CA2156075A1 (en) Aerosol formulation containing a dispersing aid
CA2004598A1 (en) Medicinal aerosol formulations
AU639514B2 (en) Bicyclam derivatives
EP1043324A4 (en) Purine derivatives and medicine containing the same as the active ingredient
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
EP1277467A3 (en) Non-chlorofluorocarbon aerosol formulations
CA2327723A1 (en) Bicyclic hydroxamic acid derivatives
CA2067184A1 (en) New linker for bioactive agents
EP0882450A3 (en) Cholesterol-lowering composition comprising coenzyme Q
CA2045212A1 (en) Anti-virus agent
AU1220192A (en) Poly-4-aminopyrrole-2-carboxyamide derivatives, processes for their preparation and pharmaceutical compositions which contain them
GEP20012439B (en) Aniline Derivatives Having Nitrogen Monoxide Synthase Inhibitory Activity and Pharmaceutical Compositions Containing the Same
IE862862L (en) Peptides
CA2129542A1 (en) Pharmaceutical preparation based on rhamnolipid
CA2179733A1 (en) Anticonvulsant pseudofructopyranose sulfamates
WO1993013739A3 (en) Retroreverse pyrrole-amidino oligopeptide anticancer agent analogues, preparation of same, and pharmaceutical compositions containing such analogues
CA2200986A1 (en) Medicaments
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
GEP20032924B (en) Novel Furan Diarylmethylidene Derivatives, Method for Their Preparation and Pharmaceutical Composition
AU1303099A (en) Herbicidal furanyl- and thienyloxyazines
CA2248794A1 (en) Medicament for preventive and treatment for viral infectious diseases

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed